Gene Activity List

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 21 of 1714:
11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
Gene Compound Assay Inh Ic50 Ki View
adrenergic, beta-1-, receptor LABETALOL Adrenergic beta1 96% .01uM .005837uM View
5-hydroxytryptamine (serotonin) receptor 2A HALOPERIDOL Serotonin 5-HT2A 96% .075uM .021uM View
histamine receptor H 1 TRAZODONE Histamine H1, Central 96% .361uM .042uM View
5-hydroxytryptamine (serotonin) receptor 1A LABETALOL Serotonin 5-HT1A 96% .393uM .225uM View
dopamine receptor D1A HALOPERIDOL Dopamine D1 96% .11uM .055uM View
sodium channel, voltage-gated, type VII, alpha CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
amiloride-sensitive cation channel 5, intestinal CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, voltage-gated, type III, beta CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, voltage-gated, type XI, alpha CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, voltage-gated, type I, beta CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, voltage-gated, type 10, alpha polypeptide CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, voltage-gated, type IV, alpha polypeptide CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, voltage-gated, type V, alpha polypeptide CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, voltage-gated, type II, beta CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, nonvoltage-gated 1 alpha CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, nonvoltage-gated 1 gamma CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, nonvoltage-gated 1 beta CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, voltage-gated, type XI, alpha CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, nonvoltage-gated 1, gamma CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, nonvoltage-gated 1, delta CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, nonvoltage-gated 1 alpha CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, voltage-gated, type X, alpha CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, voltage-gated, type IX, alpha CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, voltage gated, type VIII, alpha CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, voltage-gated, type VII, alpha CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, voltage-gated, type IV, beta CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, voltage-gated, type IV, alpha CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, voltage-gated, type III, alpha CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, voltage-gated, type II, beta CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, voltage-gated, type II, alpha 2 CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, voltage-gated, type I, beta CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, voltage-gated, type I, alpha CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, voltage-gated, type IV, beta CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel associated protein 1 CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel associated protein 2 CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, voltage-gated, type III, beta CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
5-hydroxytryptamine receptor 6 CYPROHEPTADINE Serotonin 5-HT6 96% .281uM .13uM View
adrenergic receptor, alpha 2a THIORIDAZINE Adrenergic alpha2A 96% .133uM .05uM View
A3 adenosine receptor MICONAZOLE Adenosine A3 96% 2.811uM 1.589uM View
adrenergic receptor, beta 3 MICONAZOLE Adrenergic beta3 96% 5.482uM 4.111uM View
histamine receptor H 2 MICONAZOLE Histamine H2 96% 6.75uM 6.637uM View
5-hydroxytryptamine (serotonin) receptor 1A ECONAZOLE Serotonin 5-HT1A 96% 16.177uM 9.244uM View
carbonic anhydrase 5a, mitochondrial CIGLITAZONE Carbonic Anhydrase 96% .086uM NoneNone View
carbonic anhydrase 3 CIGLITAZONE Carbonic Anhydrase 96% .086uM NoneNone View
carbonic anhydrase 2 CIGLITAZONE Carbonic Anhydrase 96% .086uM NoneNone View
carbonic anhydrase 4 CIGLITAZONE Carbonic Anhydrase 96% .086uM NoneNone View
carbonic anhydrase XI CIGLITAZONE Carbonic Anhydrase 96% .086uM NoneNone View
carbonic anhydrase IX CIGLITAZONE Carbonic Anhydrase 96% .086uM NoneNone View
carbonic anhydrase VIII CIGLITAZONE Carbonic Anhydrase 96% .086uM NoneNone View
carbonic anhydrase VII CIGLITAZONE Carbonic Anhydrase 96% .086uM NoneNone View
carbonic anhydrase VA, mitochondrial CIGLITAZONE Carbonic Anhydrase 96% .086uM NoneNone View
carbonic anhydrase IV CIGLITAZONE Carbonic Anhydrase 96% .086uM NoneNone View
carbonic anhydrase III, muscle specific CIGLITAZONE Carbonic Anhydrase 96% .086uM NoneNone View
carbonic anhydrase I CIGLITAZONE Carbonic Anhydrase 96% .086uM NoneNone View
carbonic anhydrase XIV CIGLITAZONE Carbonic Anhydrase 96% .086uM NoneNone View
carbonic anhydrase VB, mitochondrial CIGLITAZONE Carbonic Anhydrase 96% .086uM NoneNone View
carbonic anhydrase XII CIGLITAZONE Carbonic Anhydrase 96% .086uM NoneNone View
carbonic anhydrase VI CIGLITAZONE Carbonic Anhydrase 96% .086uM NoneNone View
carbonic anhydrase II CIGLITAZONE Carbonic Anhydrase 96% .086uM NoneNone View
A3 adenosine receptor AURANOFIN Adenosine A3 96% 1.688uM .954uM View
5-hydroxytryptamine (serotonin) receptor 2C LY-294002 Serotonin 5-HT2C 96% 1.002uM .525uM View
androgen receptor MEDROXYPROGESTERONE Testosterone 96% .137uM .091uM View
5-hydroxytryptamine receptor 6 DIETHYLSTILBESTROL Serotonin 5-HT6 96% 12.892uM 5.986uM View
adenosine A1 receptor DIETHYLSTILBESTROL Adenosine A1 96% 2.856uM 1.666uM View
adrenergic receptor, beta 2 METOPROLOL Adrenergic beta2 96% 2.573uM 1.769uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, voltage-gated, type IV, beta DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, voltage-gated, type IV, alpha DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, voltage-gated, type III, alpha DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, voltage-gated, type II, beta DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, voltage-gated, type II, alpha 2 DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, voltage-gated, type I, beta DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, voltage-gated, type I, alpha DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
protein kinase C, theta PACLITAXEL Phorbol Ester 19% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel associated protein 1 DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel associated protein 2 DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, voltage-gated, type III, beta DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
5-hydroxytryptamine (serotonin) receptor 2A GUANABENZ Serotonin 5-HT2A 96% .392uM .112uM View
sodium channel, voltage-gated, type I, alpha CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
sodium channel, voltage-gated, type IX, alpha CYPROHEPTADINE Sodium Channel, Site 2 96% 1.167uM 1.065uM View
Cytochrom P450-2D6 monooxygenase PROPAFENONE CYP450-2D6 Inhibition 96% 4.6034uM NoneNone View
Cytochrom P450-2D6 monooxygenase AMBROXOL CYP450-2D6 Inhibition 96% .5574uM NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 SULOCTIDIL Adrenergic, Norepinephrine Transporter 96% 1.4004uM 1.3888uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 DESLORATADINE Serotonin Transporter 96% .23uM .122uM View
5-hydroxytryptamine (serotonin) receptor 2C CYCLIZINE Serotonin 5-HT2C 96% 1.021uM .535uM View
5-hydroxytryptamine (serotonin) receptor 2B ACLARUBICIN Serotonin 5-HT2B 96% 1.106uM .704uM View
5-hydroxytryptamine (serotonin) receptor 2A FLUNARIZINE Serotonin 5-HT2A 96% .407uM .116uM View
cholinergic receptor, muscarinic 4 DESLORATADINE Muscarinic M4 96% .339uM .047uM View
cholinergic receptor, muscarinic 5 METHSCOPOLAMINE BROMIDE Muscarinic M5 96% .000446uM .00032uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 FLUNARIZINE Dopamine Transporter 96% .584uM .464uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 4-NONYLPHENOL Dopamine Transporter 96% 1.649uM 1.31uM View
dopamine receptor 2 FLUNARIZINE Dopamine D2L 96% .352uM .117uM View
dopamine receptor 2 SULPIRIDE Dopamine D2L 96% .205uM .068uM View
calcium channel, voltage-dependent, gamma subunit 8 TERFENADINE Calcium Channel Type L, Benzothiazepine 96% .226uM .201uM View
calcium channel, voltage-dependent, gamma subunit 7 TERFENADINE Calcium Channel Type L, Benzothiazepine 96% .226uM .201uM View
calcium channel, voltage-dependent, gamma subunit 6 TERFENADINE Calcium Channel Type L, Benzothiazepine 96% .226uM .201uM View
calcium channel, voltage-dependent, gamma subunit 5 TERFENADINE Calcium Channel Type L, Benzothiazepine 96% .226uM .201uM View
calcium channel, voltage-dependent, gamma subunit 4 TERFENADINE Calcium Channel Type L, Benzothiazepine 96% .226uM .201uM View
calcium channel, voltage-dependent, gamma subunit 3 TERFENADINE Calcium Channel Type L, Benzothiazepine 96% .226uM .201uM View
calcium channel, voltage-dependent, gamma subunit 2 TERFENADINE Calcium Channel Type L, Benzothiazepine 96% .226uM .201uM View
calcium channel, voltage-dependent, gamma subunit 1 TERFENADINE Calcium Channel Type L, Benzothiazepine 96% .226uM .201uM View
calcium channel, voltage-dependent, beta 4 subunit TERFENADINE Calcium Channel Type L, Benzothiazepine 96% .226uM .201uM View
calcium channel, voltage-dependent, beta 3 subunit TERFENADINE Calcium Channel Type L, Benzothiazepine 96% .226uM .201uM View
calcium channel, voltage-dependent, beta 2 subunit TERFENADINE Calcium Channel Type L, Benzothiazepine 96% .226uM .201uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit TERFENADINE Calcium Channel Type L, Benzothiazepine 96% .226uM .201uM View
calcium channel, voltage-dependent, alpha 1F subunit TERFENADINE Calcium Channel Type L, Benzothiazepine 96% .226uM .201uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit TERFENADINE Calcium Channel Type L, Benzothiazepine 96% .226uM .201uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit TERFENADINE Calcium Channel Type L, Benzothiazepine 96% .226uM .201uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit TERFENADINE Calcium Channel Type L, Benzothiazepine 96% .226uM .201uM View
calcium channel, voltage-dependent, beta 1 subunit TERFENADINE Calcium Channel Type L, Benzothiazepine 96% .226uM .201uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit TERFENADINE Calcium Channel Type L, Benzothiazepine 96% .226uM .201uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit TERFENADINE Calcium Channel Type L, Benzothiazepine 96% .226uM .201uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 TERFENADINE Calcium Channel Type L, Benzothiazepine 96% .226uM .201uM View
Cytochrom P450-2D6 monooxygenase BUTENAFINE CYP450-2D6 Inhibition 96% .3uM NoneNone View
Cytochrom P450-2D6 monooxygenase EPERISONE CYP450-2D6 Inhibition 96% 4.9034uM NoneNone View
Cytochrom P450-2D6 monooxygenase OXYMETAZOLINE CYP450-2D6 Inhibition 96% .2uM NoneNone View
Cytochrom P450-2D6 monooxygenase PROCHLORPERAZINE CYP450-2D6 Inhibition 96% .3uM NoneNone View
Cytochrom P450-2D6 monooxygenase PROMAZINE CYP450-2D6 Inhibition 96% .3uM NoneNone View
Cytochrom P450-2C19 monooxygenase TOLNAFTATE CYP450-2C19 Inhibition 96% 3uM NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) ALPHA-ERGOCRYPTINE Adrenergic alpha1D 96% .048uM .024uM View
5-hydroxytryptamine (serotonin) receptor 1A MOXONIDINE Serotonin 5-HT1A 96% .7021uM .4012uM View
adrenergic receptor, alpha 2b METHYLERGONOVINE Adrenergic alpha2B 96% .461uM .21uM View
dopamine receptor D3 BENZTROPINE Dopamine D3 96% .654uM .222uM View
adrenergic receptor, alpha 1a MAPROTILINE Adrenergic alpha1A 96% .567uM .23uM View
dopamine receptor D3 MAPROTILINE Dopamine D3 96% .645uM .219uM View
5-hydroxytryptamine (serotonin) receptor 2B MAPROTILINE Serotonin 5-HT2B 96% .336uM .214uM View
histamine receptor H 1 MAPROTILINE Histamine H1, Central 96% .008792uM .001021uM View
A3 adenosine receptor IVERMECTIN Adenosine A3 96% .5121uM .2894uM View
histamine receptor H 1 LISURIDE Histamine H1, Central 96% .16uM .019uM View
dopamine receptor D1A LISURIDE Dopamine D1 96% .173uM .086uM View
sodium channel, voltage-gated, type I, alpha DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, voltage-gated, type IX, alpha DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, voltage-gated, type VII, alpha DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
amiloride-sensitive cation channel 5, intestinal DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, voltage-gated, type III, beta DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, voltage-gated, type XI, alpha DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, voltage-gated, type I, beta DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, voltage-gated, type 10, alpha polypeptide DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, voltage-gated, type IV, alpha polypeptide DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, voltage-gated, type V, alpha polypeptide DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
sodium channel, voltage-gated, type II, beta DIHYDROERGOCRISTINE MESYLATE Sodium Channel, Site 2 96% 2.271uM 2.071uM View
5-hydroxytryptamine (serotonin) receptor 2A ERGOTAMINE Serotonin 5-HT2A 96% .006486uM .001853uM View
adrenergic receptor, alpha 2b DIHYDROERGOCRISTINE MESYLATE Adrenergic alpha2C 96% .00865uM .001257uM View
adrenergic receptor, alpha 2c (Non-specific probe) DIHYDROERGOCRISTINE MESYLATE Adrenergic alpha2C 96% .00865uM .001257uM View
5-hydroxytryptamine (serotonin) receptor 2A QUETIAPINE Serotonin 5-HT2A 96% .1178uM .0336uM View
adrenergic receptor, alpha 2b QUETIAPINE Adrenergic alpha2C 96% .4208uM .0611uM View
adrenergic receptor, alpha 2c (Non-specific probe) QUETIAPINE Adrenergic alpha2C 96% .4208uM .0611uM View
5-hydroxytryptamine (serotonin) receptor 2B PROMAZINE Serotonin 5-HT2B 96% .347uM .221uM View
cholinergic receptor, muscarinic 1 PAROXETINE Muscarinic M1 96% .145uM .035uM View
calcium channel, voltage-dependent, gamma subunit 8 TERCONAZOLE Calcium Channel Type L, Phenylalkylamine 96% 3.455uM 3.359uM View
calcium channel, voltage-dependent, gamma subunit 7 TERCONAZOLE Calcium Channel Type L, Phenylalkylamine 96% 3.455uM 3.359uM View
calcium channel, voltage-dependent, gamma subunit 6 TERCONAZOLE Calcium Channel Type L, Phenylalkylamine 96% 3.455uM 3.359uM View
calcium channel, voltage-dependent, gamma subunit 5 TERCONAZOLE Calcium Channel Type L, Phenylalkylamine 96% 3.455uM 3.359uM View
calcium channel, voltage-dependent, gamma subunit 4 TERCONAZOLE Calcium Channel Type L, Phenylalkylamine 96% 3.455uM 3.359uM View
calcium channel, voltage-dependent, gamma subunit 3 TERCONAZOLE Calcium Channel Type L, Phenylalkylamine 96% 3.455uM 3.359uM View
calcium channel, voltage-dependent, gamma subunit 2 TERCONAZOLE Calcium Channel Type L, Phenylalkylamine 96% 3.455uM 3.359uM View
calcium channel, voltage-dependent, gamma subunit 1 TERCONAZOLE Calcium Channel Type L, Phenylalkylamine 96% 3.455uM 3.359uM View
calcium channel, voltage-dependent, beta 4 subunit TERCONAZOLE Calcium Channel Type L, Phenylalkylamine 96% 3.455uM 3.359uM View
calcium channel, voltage-dependent, beta 3 subunit TERCONAZOLE Calcium Channel Type L, Phenylalkylamine 96% 3.455uM 3.359uM View
calcium channel, voltage-dependent, beta 2 subunit TERCONAZOLE Calcium Channel Type L, Phenylalkylamine 96% 3.455uM 3.359uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit TERCONAZOLE Calcium Channel Type L, Phenylalkylamine 96% 3.455uM 3.359uM View
calcium channel, voltage-dependent, alpha 1F subunit TERCONAZOLE Calcium Channel Type L, Phenylalkylamine 96% 3.455uM 3.359uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit TERCONAZOLE Calcium Channel Type L, Phenylalkylamine 96% 3.455uM 3.359uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit TERCONAZOLE Calcium Channel Type L, Phenylalkylamine 96% 3.455uM 3.359uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit TERCONAZOLE Calcium Channel Type L, Phenylalkylamine 96% 3.455uM 3.359uM View
calcium channel, voltage-dependent, beta 1 subunit TERCONAZOLE Calcium Channel Type L, Phenylalkylamine 96% 3.455uM 3.359uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit TERCONAZOLE Calcium Channel Type L, Phenylalkylamine 96% 3.455uM 3.359uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit TERCONAZOLE Calcium Channel Type L, Phenylalkylamine 96% 3.455uM 3.359uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 TERCONAZOLE Calcium Channel Type L, Phenylalkylamine 96% 3.455uM 3.359uM View
progesterone receptor 17-METHYLTESTOSTERONE Progesterone 96% .251uM .033uM View
progesterone receptor 17-METHYLTESTOSTERONE Progesterone 96% .251uM .033uM View
adrenergic receptor, alpha 1b PENTAMIDINE Adrenergic alpha1B 96% .967uM .535uM View
5-hydroxytryptamine (serotonin) receptor 1A METERGOLINE Serotonin 5-HT1A 96% .006175uM .003528uM View
5-hydroxytryptamine receptor 6 PROCHLORPERAZINE Serotonin 5-HT6 96% .267uM .124uM View
opioid receptor, sigma 1 PROCHLORPERAZINE Sigma1 96% .054uM .023uM View
5-hydroxytryptamine (serotonin) receptor 2B PROCHLORPERAZINE Serotonin 5-HT2B 96% .102uM .065uM View
adrenergic receptor, alpha 2b PRAZOSIN Adrenergic alpha2B 96% .29uM .133uM View
opioid receptor, delta 1 GW-1929 Opiate delta 96% 3.209uM 1.131uM View
potassium voltage-gated channel, subfamily H (eag-related), member 5 BENZETHONIUM CHLORIDE Potassium Channel HERG 97% .1085uM .0889uM View
potassium voltage-gated channel, subfamily H (eag-related), member 3 BENZETHONIUM CHLORIDE Potassium Channel HERG 97% .1085uM .0889uM View
potassium voltage-gated channel, subfamily H (eag-related), member 4 BENZETHONIUM CHLORIDE Potassium Channel HERG 97% .1085uM .0889uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 BENZETHONIUM CHLORIDE Potassium Channel HERG 97% .1085uM .0889uM View
potassium voltage-gated channel, subfamily H (eag-related), member 1 BENZETHONIUM CHLORIDE Potassium Channel HERG 97% .1085uM .0889uM View
adenosine A1 receptor 3,3',5-TRIIODO-L-THYRONINE Adenosine A1 97% .4109uM .2397uM View
5-hydroxytryptamine (serotonin) receptor 2B SULOCTIDIL Serotonin 5-HT2B 97% .939uM .5975uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 4-NONYLPHENOL Serotonin Transporter 97% 3.38uM 1.795uM View
5-hydroxytryptamine (serotonin) receptor 2B THIORIDAZINE Serotonin 5-HT2B 97% .129uM .082uM View
cholinergic receptor, muscarinic 5 DIMENHYDRINATE Muscarinic M5 97% .316uM .227uM View
cholinergic receptor, muscarinic 1 DESLORATADINE Muscarinic M1 97% .267uM .064uM View
calcium channel, voltage-dependent, gamma subunit 8 THIORIDAZINE Calcium Channel Type L, Phenylalkylamine 97% .443uM .431uM View
calcium channel, voltage-dependent, gamma subunit 7 THIORIDAZINE Calcium Channel Type L, Phenylalkylamine 97% .443uM .431uM View
calcium channel, voltage-dependent, gamma subunit 6 THIORIDAZINE Calcium Channel Type L, Phenylalkylamine 97% .443uM .431uM View
calcium channel, voltage-dependent, gamma subunit 5 THIORIDAZINE Calcium Channel Type L, Phenylalkylamine 97% .443uM .431uM View
calcium channel, voltage-dependent, gamma subunit 4 THIORIDAZINE Calcium Channel Type L, Phenylalkylamine 97% .443uM .431uM View